[Menu] [Previous] [Next]

TUTORIAL: Clinical PET Cases - Neurology - Credits and References

 Use the "Menu" button to jump to the Let's Play PET Main Menu or click on the Next (right arrowhead) and Previous (left arrowhead) buttons to proceed sequentially through the topics and tutorials. Or, you can return to the Department of Molecular and Medical Pharmacology's Home Page.

Credits

 Material for this section was kindly provided by:

Jamshid Maddahi, M.D.
Dept. of Molecular and Medical Pharmacology
UCLA School of Medicine

References

  1. Abou-Khalil, B, Siegel, G, Sackellares, J, Gilman, S, Hichwa, R, Marshall, R. Positron emission tomography studies of cerebral glucose metabolism in chronic partial epilepsy. Ann Neurol, 22:480-6, 1987.

  2. Andreasen, N: Brain imaging: Applications in psychiatry. Science, 239:1381-1388, 1988.

  3. Antonini, A, Leenders, K, Reist, H, Thomann, R, Beer, H, Locher, J. Effect of age on D2-dopamine receptors in normal human brain measured by positron emission tomography and C-11 raclopride. Arch Neurol, 50:474-80, 1993.

  4. Azari, N, Pettigrew, K, Schapiro, M, Haxby, J, Grady, C, et al: Early detection of Alzheimer's disease: A statistical approach using positron emission tomographic data. J Cereb Blood Flow Metab, 13:438-47, 1993.

  5. Baron J. Depression of energy metabolism in distant brain structures: studies with positron emission tomography in stroke patients. Sem Neurol, 9:281-5, 1989.

  6. Baxter, L Jr, Mazziotta, J, Pahl, J, Grafton, S, et al: Psychiatric, genetic, and positron emission tomographic evaluation of persons at risk for Huntington's disease. Arch Gen Psychiat, 49:148-54, 1992.

  7. Benson, D, Kuhl, D, Hawkins, R, Phelps, M, et al., The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol 40:711-14, 1983.

  8. Bernardi, S, Trimble, M, Frackowiak, R, Wise, R, Jones, T. An interictal study of partial epilepsy using positron emission tomography and the oxygen-15 inhalation technique. J Neurol Neurosurg Psychiatr, 46:473-7, 1983.

  9. Bhatt, M, Snow, B, Martin, W, et al: Positron emission tomography suggests that the rate of progression of idiopathic Parkinsonism is slow. Ann Neurol, 29:673-7, 1991.

  10. Bjšrklund, A: Neural transplantationĐan experimental tool with clinical possibilities. Trends Neurosci, 14:319-22, 1991.

  11. Blin, J, Baron, J, Dubois, B, Crouzel, C, Fiorelli, M, Attarlevy, D, Pillon, B, Fournier, D, Vidailhet, M, Agid, Y. Loss of brain 5-HT(2) receptors in Alzheimer's disease - invivo assessment with positron emission tomography and [F-18]setoperone. Brain, 116: 497-510, 1993.

  12. Brooks, D: Detection of preclinical Parkinson's disease with PET. Neurology, 41(Suppl 2):24-7, 1991.

  13. Burn D; Brooks D. Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET study. Neurology, 43:552-6, 1993.

  14. Burn, D, Mark, M, Playford, E, Maraganore, D, Zimmerman, T, Duvoisin, R, Harding, A, Marsden, C, Brooks, D: Parkinson's disease in twins studied with 18F-dopa and positron emission tomography. Neurology, 42:1894-1900, 1992.

  15. Chawluk, J, Alavi, A, Dann, R, Hurtig, H, et al. Positron emission tomography in aging and dementia: Effect of cerebral atrophy. J Nucl Med, 28:431-7, 1987.

  16. Chugani H; Hovda D; Villablanca J; Phelps M; Xu W. Metabolic maturation of the brain: a study of local cerebral glucose utilization in the developing cat. J Cereb Blood Flow Metab, 11:35-47, 1991

  17. Chugani, H and Phelps, M: PET in children with seizures. Appl Rad , 17:37-49, 1988.

  18. Chugani, H, Phelps, M and Mazziotta, J: Metabolic assessment of functional maturation and neuronal plasticity in the human brain. Neurobiology of Early Infant Behavior , 323-330, 1991.

  19. Chugani, H, Phelps, M, Shewmon, A and Barnes, D: Cerebral glucose utilization in intractable neonatal seizures and in the developing brain. Neonatal Seizures, 169-179, 1990.

  20. Chugani, H, Shewmon, D, Shields, W, Peacock, W and Phelps, M: Pediatric epilepsy surgery: Pre- and postoperative evaluation with PET. J Epilepsy , 3:75-82, 1990.

    Chugani, H, Shewmon, A, Shields, W, Sankar, R, Comair, Y, Vinters, H, Peacock, W: Surgery for intractable infantile spasms: Neuroimaging perspectives. Epilepsia, 34:764-71, 1993.

  21. Chugani, H and Phelps, M: Imaging human brain development with positron emission tomography. J Nucl Med, 32:23-6, 1991.

  22. Chugani, H and Phelps, M: Maturational changes in cerebral function in infants determined by 18FDG positron emission tomography. Science, 231:840-3, 1986.

  23. Chugani, H, Mazziotta, J and Phelps, M: Sturge-Weber syndrome: a study of cerebral glucose utilization with positron emission tomography. J Pediatr , 114:244-53, 1989.

  24. Chugani, H, Mazziotta, J, Engel, J, Jr and Phelps, M: The Lennox-Gastaut syndrome: metabolic subtypes determined by 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography. Ann Neurol, 21:4-13, 1987.

  25. Chugani, H, Phelps, M and Mazziotta, J: Positron emission tomography study of human brain functional development. Ann Neurol, 22:487-97, 1987.

  26. Chugani, H, Shewmon, D, Peacock, W, Shields, W, Mazziotta, J and Phelps, M: Surgical treatment of intractable neonatal-onset seizures: the role of positron emission tomography. Neurology, 38:1178-88, 1988.

    Chugani, H, Shewmon, D, Sankar, R, Chen, B and Phelps, M: Infantile Spasms .2. Lenticular Nuclei And Brain Stem Activation On Positron Emission Tomography. Ann Neurol, 31:212-9, 1992.

  27. Chugani, H, Shields, W, Shewmon, D, Olson, D, Phelps, M and Peacock, W: Infantile Spasms .1. PET Identifies Focal Cortical Dysgenesis In Cryptogenic Cases For Surgical Treatment. Ann Neurol, 27:406-13, 1990.

  28. Corbetta, M, Miezin, F, Dobmeyer, S, Shulman, G, Petersen, S: Attentional modulation of neural processing of shape, color, and velocity in humans. Science, 248:1556-9, 1990.

  29. Corbetta, M, Miezin, F, Dobmeyer, S, Shulman, G, Petersen, S: Selective and divided attention during visual discrimination of shape, color, and speed: functional anatomy by positron emission tomography. J Neurosci, 11:2383-2402. 1991.

  30. Corbetta, M, Miezin, F, Shulman, G, Petersen, S: A PET study of visuospatial attention. J Neurosci, 13:1202-26, 1993.

  31. DeCarli, C, Kaye, J, Horwitz, B, Rapoport, S, Critical analysis of the use of computer-assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type. Neurology, 40:872-83, 1990.

  32. DeLeon, M, George, A, Marcus, D, Miller, D. Positron emission tompgraphy with the deoxyglucose technique and the diagnosis of Alzheimer's disease. Neurobiol Aging 9:88-90, 1988.

  33. DeLeon, N, Ferris, S, George, A, et al., Computed tomography and positron emission transacial tomography evaluations of normal aging and Alzheimer's disease. J Cereb Blood Flow Metab, 3:391-4, 1983.

  34. Dewey S; MacGregor R; Brodie J; Bendriem B; King P; Volkow N; Schlyer D; Fowler J; Wolf A; Gatley S. Mapping muscarinic receptors in human and baboon brain using [N-11C-methyl] - benztropine. Synapse, 5:213-23, 1990.

  35. Dewey S; Smith G; Logan J; Brodie J. Modulation of central cholinergic activity by GABA and serotonin: PET studies with 11C-benztropine in primates. Neuropsychopharmacology, 8:371-376, 1993.

  36. Dewey S; Smith G; Logan J; Brodie J; Fowler J; Wolf A. Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse, 13:350-6, 1993.

  37. Dewey S; Smith G; Logan J; Brodie J; Yu D; Ferrieri R; King P; MacGregor R; Martin T; Wolf A. GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography. J Neurosci, 12:3773-80, 1992.

  38. Duara, R. Dementia. In J Mazziotta and S Gidman, (Eds): Clinical Brain Imaging: Principles and Applications. Davis, Philadelphia, 1992, pp. 294-349.

  39. Duncan R. Epilepsy, cerebral blood flow, and cerebral metabolic rate. Cerebrovasc Brain Metab Rev, 4:105-21, 1992

  40. Eberling, J, Reed, B, Baker, M, Jagust, W. Cognitive correlates of regional cerebral blood flow in Alzheimer's disease. Arch Neurol, 50: 761-766, 1993.

  41. Eidelberg, D: PET studies in parkinsonism. Neurol Clin, 10:421-433, 1992.

  42. Engel, J Jr., Kuhl, D, Phelps, M. Patterns of human local cerebral glucose metabolism during epileptic seizures. Science, 218:64-6, 1982.

  43. Engel, J Jr.: The use of positron emission tomographic scanning in epilepsy. Ann Neurol, 15(suppl):S180-S191, 1984.

  44. Foster, N, Chase, T, Mansi, L, Brooks, R, et al., Cortical abnormalities in Alzheimer's Disease. Ann Neurol 16:649-654, 1984.

  45. Fowler J; Volkow N; Wolf A; Dewey S; Schlyer D; Macgregor R; Hitzemann R; Logan J; Bendriem B; Gatley S. Mapping cocaine binding sites in human and baboon brain in vivo. Synapse, 4:371-7, 1989.

  46. Fox, P, Miezin, F, Sllman, J, Van Essen, D, Raichle, M: Retinotopic organization of human visual cortex mapped with positron emission tomography. J Neurosci, 7:913-922, 1987.

  47. Fox, P, Mintun, M: Noninvasive functional brain mapping by change-distribution analysis of averaged PET images of H2[15O], J Nucl Med, 30:141-9, 1989.

  48. Frackowiak, R, Pozzilli, G, Legg, N, DuBoulay, G, et al., Regional cerebral oxygen supply and utilization in dementia. Brain, 104:753-78, 1981.

  49. Freed, C, Breeze, R, Rosenberg, N, Schneck, S, Wells, T, Barrett, J, Grafton, S, Mazziotta, J, Eidelberg, D, Rottenberg, D: Therapeutic effects of fetal dopamine cells transplanted in a patient with Parkinson's disease. Prog Brain Res, 82:715-21, 1990.

    Friedland, R, Budinger, T, Koss, E, Ober, B. Alzheimer's disease: Anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci Lett 53:235-40, 1985.

  50. Friston K; Frith C; Liddle P; Frackowiak R. Investigating a network model of word generation with positron emission tomography. Proc Roy Soc Lond B Biol Sci, 244:101-6, 1991.

  51. Friston, K, Frith, C, Liddle, P, Frackowiak, R: Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab, 11:690-9, 1991.

  52. Frith, C, Friston, K, Liddle, P, Frackowiak, R: A PET study of word finding. Neuropsychologia, 29:1137-48, 1991.

  53. Frost J. Imaging the serotonergic system by positron emission tomography. Ann NY Acad Sci, 600:273-80, 1990.

  54. Frost, J. Receptor imaging by PET and SPECT - Focus on the opiate receptor. J Recept Res 13:1-4, 1993.

  55. Goto, I, Taniwaki, T, Hosokawa, S, Otsuka, M, Ichiya,Y, Ichimiya, A: Positron emission tomographic (PET) studies in dementia. J Neurol Sci, 114:1-6, 1993.

  56. Grady, C, Haxby, J, Horwitz, B et al., Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer's type. J. Clin. Exp. Neuropsychol., 10:576-96, 1988.

  57. Grafton, S, Woods, R, Mazziotta, J, Phelps, M: Somatotopic mapping of the primary motor cortex in humans: activation studies with cerebral blood flow and positron emission tomography. J Neurophysiol, 66:735-43, 1991.

  58. Grasby, P, Frith, C, Friston, K, Bench, C, Frackowiak, R, Dolan, R: Functional mapping of brain areas implicated in auditory-verbal memory function. Brain, 116:1-20, 1993.

  59. Haxby J; Grady C; Horwitz B; Ungerleider L; Mishkin M; Carson R; Herscovitch P; Schapiro M; Rapoport S. Dissociation of object and spatial visual processing pathways in human extrastriate cortex. Proc Natl Acad Sci USA, 88:1621-5, 1991.

  60. Haxby, J, Duara, R, Grady, C, Cutler, N, Rapoport, S: Relations between neuropsychological and cerebral asymmetries in early Alzheimer's disease. J Cereb Blood Flow Metab, 5:193-200, 1985.

  61. Hayden, M, Martin, W, Stoessl, A, et al. Positron emission tomography in the early diagnosis of Huntington's disease. Neurology 36:888-94, 1986.

  62. Heiss W; Pawlik G; Holthoff V; Kessler J; Szelies B. PET correlates of normal and impaired memory functions. Cerebrovasc Brain Metab Rev, 4:1-27, 1992.

  63. Heiss, W, Szelies, B, Adams, R, Kessler, J, Pawlik, G, Herholz, K. PET criteria for diagnosis of Alzheimer's disease and other dementias. In K Maurer, P Riederer and H Beckmann, Eds., Alzheimers Disease: Epidemiology, Neuropathology, Neurochemistry, and Clinics, Springer-Verlag, Berlin, 1990, pp.473-87.

  64. Henry, T, Engel, J Jr, Babbs, T, Phelps, M. Correlation of neuronal cell loss with degreee of interictal focal temporal hypometabolism in complex partial epilepsy. Neurology, 38(Suppl 1):156, 1988.

  65. Henry, T, Mazziotta, J, Engel, J. Interictal metabolic anatomy of mesial temporal lobe epilepsy. Arch Neurol, 50:582-9, 1993.

  66. Hoffman J; Melega W; Hawk T; Grafton S; Luxen A; Mahoney D; Barrio J; Huang S; Mazziotta J; Phelps M. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography. J Nucl Med, 33:1472-7, 1992.

  67. Hoffman, J, Waskin, H, Schifter, T, Hanson, M, Gray, L, Rosenfeld, S, Coleman, R: FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med, 34:567-575, 1993.

  68. Holthoff, V, Koeppe, R, Frey, K, Penney, J, Markel, D, Kuhl, D, Young, A. Positron emission tomography measures of benzodiazepine receptors in Huntingtons disease. Ann Neurol, 34: 76-81, 1993.

  69. Hopfensperger, K, Koller, W: Recognizing early Parkinson's disease. Postgrad. Med., 90:49-59.

  70. Hoyer, S. Changes in brain energy metabolism and the early detection of Alzheimers disease. In: Early Markers in Parkinsons and Alzheimers Diseases, 1990, pp. 233-44.

  71. Hume S; Myers R; Bloomfield P; Opacka-Juffry J; Cremer J; Ahier R; Luthra S; Brooks D; Lammertsma A. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse, 12:47-54, 1992.

  72. Iacono, R, Tang, Z, Mazziotta, J, Grafton, S, Hoehn, M: Bilateral fetal grafts for Parkinson's disease: 22 months results. Stereotact Funct Neurosurg, 58:84-87, 1992.

  73. Jagust, W, et al., Diminished glucose transport in Alzheimer's disease: Dynamic PET studies. J Cereb Blood Flow Metab, 11:323-30, 1991.

  74. Jones A; Brown W; Friston K; Qi L; Frackowiak R. Cortical and subcortical localization of response to pain in man using positron emission tomography. Proc Roy Soc Lond B Biol Sci, 244:39-44, 1991.

  75. Jonides, J, Smith, E, Koeppe, R, Awh, E, Minoshima, S, Mintun, M. Spatial working memory in humans as revealed by PET. Nature, 363:623-5, 1993.

  76. Karbe, H, Holthoff, V, Huber, M, Herholz, K, Wienhard, K, Wagner, R, Heiss, W: Positron emission tomography in degenerative disorders of the dopaminergic system. J Neural Transm, 4:121-30, 1992.

  77. Kempler, D, Metter, E, Jackson, C, Hanson, W, Riege, W, Mazziotta, J, Phelps, M: Disconnection and cerebral metabolism. The case for aphasia. Arch Neurol, 45:277-9, 1988.

  78. Kerrigan, J, Chugani, H and Phelps, M: Regional cerebral glucose metabolism in clinical subtypes of cerebral palsy. Pediatric Neurol, 7:415-25, 1991.

  79. Kish, S, Shannak, K, Hornykiewicz, O: Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N Engl J Med, 318:876-880, 1988.

  80. Kopin I. In-vivo quantitative imaging of catecholaminergic nerve terminals in brain and peripheral organs using positron emission tomography (PET). J Neural Transm Suppl, 32:19-27, 1990.

  81. Kosslyn, S, Alpert, N, Thompson, W, Maljkovic, V, Weise, S, Chabris, C, Hamilton, S, Rauch, S, Buonanno, F. Visual mental imagery activates topographically organized visual cortex - PET investigations. J Cog Neurosci, 5: 263-287, 1993.

  82. Kuhl, D, Metter, J, Benson, D, Ashford, J, Riege, W, et al: Similarities of cerebral glucose metabolism in Alzheimer's and Parkinsonian dementia. J Cereb Blood Flow Metab, 5[Suppl 1]:169-170, 1985.

  83. Kuhl, D, Phelps, M, Markham, C, et al. Cerebral metabolism and atrophy in Huntington's disease determined by 18-FDG and computed tomographic scan. Ann Neurol, 12:425-34, 1982.

  84. Kumar, A, et al., High resolution PET studies in Alzheimer's disease. Neuropsychopharmacology, 4:35-46, 1991.

  85. Kuwert, T, Lange, H, Langen, K-J, Herzog, H, Aulich, A, Feinendegen, L: Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain, 113:1405-23, 1990.

  86. Latack, J, Abou-Khalil, B, Siegel, G, Sackellares, J, Gabrielsen, T, Aisen, A. Patients with partial seizures: Evaluation by MR, CT, and PET imaging. Radiology 159:159-63, 1986.

  87. Leenders, K, Salmon, E, Tyrrell, P., et al: The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch Neurol, 47:1290-8, 1990.

  88. Leenders, K: Characterization of Parkinson's disease using positron emission tomography. In: Dostert, P, et al., Eds. Early Markers in Parkinson's and Alzheimer's Diseases. Springer-Verlag, 1990, pp 59-69.

  89. Lindvall, O: Prospects of transplantation in human neurodegenerative diseases. Trends Neurosci, 14:376-84, 1991.

  90. Lucignani, G, Schmidt, K, Moresco, R, Striano, G, Colombo, F, Sokoloff, L, Fazio, F: Measurement of regional cerebral glucose utilization with fluorine-18-FDG and PET in heterogenous tissues: Theoretical considerations and practical procedure. J Nucl Med, 34:360-369, 1993.

  91. Madsen, P, Holm, S, Vorstrup, S, Friberg, L, Lassen, N, Wildschiodtz, G: Human regional cerebral blood flow during rapid-eye movement sleep. J Cereb Blood Flow Metab, 11:502-507, 1991.

  92. Maziere M; Khalili-Varasteh M; Delforge J; Janier M; Leguludec D; Prenant C; Syrota A. Positron emission tomography and cholinergic mechanisms: an overview. Prog Brain Res, 1990, 84:347-59.

  93. Mazziotta, J, Gilman, S., Eds. Clinical Brain Imaging: Principles and Applications. Davis, Philadelphia, 1992.

  94. Mazziotta, J, Phelps, M, Carson, R, Kuhl, D: Tomographic mapping of human cerebral metabolism: Auditory stimulation. Neurology, 32:921-36, 1982.

  95. Mazziotta, J. Huntington's disease: Studies with structural imaging techniques and positron emission tomography. Semin Neurol, 9:360-9, 1989.

  96. McGeer, P, Kamo, H, Harrop, R, et al., Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease. Neurology, 36:1569-74, 1986.

  97. Nagasawa, H, Saito, H, Kogure, K, Hatazawa, J, Itoh, M, et al: 6-[18F]Fluorodopa metabolism in patients with hemiparkinsonism studied by positron emission tomography. J Neurol Sci, 115:136-43, 1993.

  98. Nyback H; Nordberg A; Langstrom B; Halldin C; Hartvig P; Ahlin A; Swahn C; Sedvall G. Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography. Prog Brain Res, 79:313-9, 1989.

  99. Olson, D, Chugani, H, Shewmon, D, Phelps, M and Peacock, W: Electrocorticographic confirmation of focal positron emission tomographic abnormalities in children with intractable epilepsy. Epilepsia , 31:731-9, 1990.

  100. Otsuka, M, Ichiya, Y, Kuwabara, Y, Hosokawa, S, Sasaki, M, et al. Cerebral glucose metabolism and striatal F-18-Dopa uptake by PET in cases of chorea with or without dementia. J Neurol Sci, 115:153-7, 1993.

  101. Paulesu, E, Frith, C, Frackowiak, R: The neural correlates of the verbal component of working memory. Nature, 362:342-4, 1993.

  102. Peppard, R, Martin, W, Carr, G, Grochowski, M et al: Cerebral glucose metabolism in Parkinson's disease with and without dementia. Arch Neurol, 49:1262-8, 1992.

  103. Perlmutter J; Kilbourn M; Welch M; Raichle M. Non-steady-state measurement of in vivo receptor binding with positron emission tomography: "dose-response" analysis. J Neurosci, 1989, 9:2344-52.

  104. Petersen, S, Fiez, J: The processing of single words studied with positron emission tomography. Annu Rev Neurosci, 16:509-30, 1993.

  105. Petrides, M, Alivisatos, B, Meyer, E, Evans, A. Functional activation of the human frontal cortex during the performance of verbal working memory tasks. Proc Natl Acad Sci USA, 90: 878-882, 1993.

  106. Phelps, M, Kuhl, D, Mazziotta, J: Metabolic mapping of the brain's response to visual stimulation: Studies in humans. Science, 211:1445-8, 1981.

  107. Phelps, M, Mazziotta, J: Positron emission tomography: Human brain function and biochemistry. Science, 228:799-809, 1985.

  108. Playford E; Brooks D. In vivo and in vitro studies of the dopaminergic system in movement disorders. Cerebrovasc Brain Metab Rev, 4:144-71, 1992.

  109. Posner, M, Petersen, S, Fox, P, Raichle, M: Localization of cognitive operations in the human brain. Science, 240:1627-31.

  110. Postiglione A; Lassen N; Holman B. Cerebral blood flow in patients with dementia of Alzheimer's type. Aging, 5:19-26, 1993.

  111. Radtke, R, Hanson, M, Hoffman, J, Crain, B, Walczak, T, Lewis, D, Beam, C, Coleman, R, Friedman, A. Temporal lobe hypometabolism on PET - Predictor of seizure control after temporal lobectomy. Neurology, 43:1088-92, 1993.

  112. Rapoport S. Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review. Cerebrovasc Brain Metab Rev, 3:297-335, 1991.

  113. Risberg, J, Gustafson, L, Brun, A. High resolution regional cerebral blood flow measurements in Alzheimers disease and other dementia disorders. In: Maurer, K, Riederer, P., Beckmann, H, Eds. Alzheimers Disease: Epidemiology, Neuropathology, Neurochemistry, and Clinics, Springer-Verlag, Berlin, 1990, pp.509-16.

  114. Sackeim, H, Prohovnik, I, Moeller, J, Mayeux, R, Stern, Y, Devanand, D. Regional cerebral blood flow in mood disorders. 2. Comparison of major depression and Alzheimer's disease. J Nucl Med, 34:1090-1101, 1993.

  115. Sawle, G, Bloomfield, P, Bjšrklund, A, et al: Transplantation of fetal dopamine neurons in Parkinson's disease: positron emission tomography [18F]-6-L-fluorodopa studies in two patients with putaminal implants. Ann Neurol, 31:166-73, 1992.

  116. Sawle, G, Myers, R. The role of positron emission tomography in the assessment of human neurotransplantation. Trends Neurosci, 16:186-92, 1993.

  117. Sawle, G, Wroe, S, Lees, A, Brooks, D, Frackowiak, R: The identification of presymptomatic Parkinsonism: Clinical and [18F]Dopa positron emission tomography studies in an Irish kindred. Ann Neurol, 32:609-17, 1992.

  118. Shinotoh, H, Hirayama, K, Tateno, Y: Dopamine D1 and D2 receptors in Parkinson's disease and striatonigral degeneration determined by PET. Adv Neurol, 60:488-93, 1993.

  119. Stefan, H, Pawlik, G, Bocher-Schwarz, H, Biersack, H, Burr, W, Penin, H, Heiss, W. Functional and morphological abnormalities in temporal lobe epilepsy: A comparison of interictal and ictal EEG, CT, MRI, SPECT, and PET. J Neurol, 234:377-84, 1987.

  120. Suhara, T, Inoue, O, Kobayashi, K, Suzuki, K, Tateno, Y. Age-related changes in human muscarinic acetylcholine receptors measured by positron emission tomography. Neurosci Lett, 149: 225-8, 1993.

  121. Suhara T; Nakayama K; Inoue O; Fukuda H; Shimizu M; Mori A; Tateno Y. D1 dopamine receptor binding in mood disorders measured by positron emission tomography. Psychopharmacology, 106:14-8, 1992.

  122. Swart J; van der Werf JF; Wiegman T; Paans AM; Vaalburg W; Korf J. In vivo binding of spiperone and N-methylspiperone to dopaminergic and serotonergic sites in the rat brain: multiple modeling and implications for PET scanning. J Cereb Blood Flow Metab, 10:297-306, 1990.

  123. Talbot J; Marrett S; Evans A; Meyer E; Bushnell M; Duncan G. Multiple representations of pain in human cerebral cortex. Science, 251:1355-8, 1991.

  124. Tavitian B; Pappata S; Planas A; Jobert A; Bonnot-Lours S; Crouzel C; DiGiamberardino L. In vivo visualization of acetylcholinesterase with positron emission tomography. Neuroreport, 4:535-8, 1993.

  125. Theodore, W, Fishbein, D, Deitz, M, Baldwin, P. Complex partial seizures: Cerebellar metabolism. Epilepsia, 28:319-23, 1987.

  126. Theodore, W, Fishbein, D, Dubinski, R. Patterns of cerebral glucose metabolism in patients with partial seizures. Neurology, 38:1201-1206, 1988.

  127. Tranel D. Neurology of language. Curr Opin Neurol Neurosurg, , 5:77-82, 1992.

  128. Vaalburg W; Coenen H; Crouzel C; Elsinga P; Langstrom B; Lemaire C; Meyer G. Amino acids for the measurement of protein synthesis in vivo by PET. Int J Radiat Appl Instr. Part B, Nucl Med Biol, 19:227-37, 1992.

  129. Volkow N; Fowler J; Wolf A. Use of positron emission tomography to study cocaine in the human brain. Nida Res Monog, 1991, 112:168-79.

  130. Watson, J, Myers, R, Frackowiak, R, Hajnal, J, Wood, R, Mazziotta, J, Shipp, S, Zeki, S. Area V5 of the human brain - Evidence from a combined study using positron emission tomography and magnetic resonance imaging. Cerebral Cortex 3:79-94, 1993.

  131. Wilson A; Scheffel U; Dannals R; Stathis M; Ravert H; Wagner H Jr. In vivo biodistribution of two [18F]-labelled muscarinic cholinergic receptor ligands: 2-[18F]- and 4-[18F]-fluorodexetimide. Life Sci, 48:1385-94, 1991.

  132. Wong, D, Wagner, H Jr, Dannals, R, Links, J, Frost, J, Ravert, H, et al: Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science, 226:1393-6, 1984.

  133. Yu, D-C, Huang, S-C, Grafton, S, Melega, W, Barrio, J, Mazziotta, J, Phelps, M: Methods for improving uptake constant of F-DOPA in PET studies. J Nucl Med, 34:679-88, 1993.

  134. Zeki S; Watson J; Lueck C; Friston K; Kennard C; Frackowiak R. A direct demonstration of functional specialization in human visual cortex. J Neurosci, 11:641-9, 1991.

Return to Top of References